Margaret Dalrymple

Margaret Dalrymple is a Senior Research Associate II at Voyager Therapeutics, Inc. since September 2023, bringing extensive experience in in vivo research and drug development. Previously at Takeda from October 2018 to August 2023, Margaret contributed to rare disease project teams, conducted complex in vivo studies in mice and rats, led in vivo imaging studies using IVIS spectrum, and mentored junior team members. Early career experience includes positions at Ikena Oncology, Shire, and Novartis Institutes for BioMedical Research, where Margaret planned and executed pharmacology studies, conducted RNA extractions, and participated in various assay methodologies. Margaret holds a Bachelor of Science degree in Biology from Northeastern University, obtained in 2019, and completed secondary education at The Peddie School.